A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder

Journal of Clinical Psychopharmacology - United States
doi 10.1097/jcp.0b013e31825d70d6

Related search